Since its founding, Cure Alzheimer’s Fund has contributed more than $40,000,000 to research, and its funded initiatives have been responsible for several key breakthroughs—including a potential treatment recently selected by the National Institutes of Health (NIH) for its elite “Blueprint” drug discovery program, and the ground-breaking “Alzheimer's in a Dish” study, which promises to greatly accelerate drug testing and was reported by The New York Times as a “giant step forward”.
Cure Alzheimer’s Fund supports some of the best scientific minds in the field of Alzheimer’s research, and it does so without any financial gain for its founders or donors. Fully 100 percent of funds raised by Cure Alzheimer’s Fund go directly to research—the Board of Directors covers all overhead expenses.Our Research Consortium is an all-star team of scientists working at premier research institutions across the country, regularly conferring with one another on the progress and impediments in their research and constantly sharing their data.
Our goal is to stop Alzheimer’s disease through early prediction, prevention and effective intervention in those patients who have become symptomatic.